Who is sponsoring NCT03498898?

NCT03498898 is sponsored by Tel-Aviv Sourasky Medical Center.

What drugs are being tested in NCT03498898?

Interventions in NCT03498898: Chronic use of Beta adrenergic receptor blocker.

What condition does NCT03498898 study?

NCT03498898 studies Nociceptive Pain.

Is NCT03498898 still recruiting?

NCT03498898 is currently status unknown. Last updated 16 August 2018.

Last reviewed 2018-08-16 · How we verify

NCT03498898

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Ongoing Beta-blockers Administration on Analgesic Requirements in the Immediate Perioperative Period.

Status unknown NA Last updated 16 August 2018

What this trial tests

NA trial testing Chronic use of Beta adrenergic receptor blocker in Nociceptive Pain in 120 participants. Status unknown.

Timeline

1 June 2018

Primary endpoint
1 October 2019

1 October 2019

Quick facts

Lead sponsor	Tel-Aviv Sourasky Medical Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	120
Start date	1 June 2018
Primary completion	1 October 2019
Estimated completion	1 October 2019
Sites	1 location across Israel

Drugs / interventions tested

Chronic use of Beta adrenergic receptor blocker

Conditions studied

Nociceptive Pain — all drugs for Nociceptive Pain →

Sponsor

Tel-Aviv Sourasky Medical Center

Who can join

Adults 18 to 75, any sex, with Nociceptive Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to discover if chronic use of Beta adrenergic receptor blockers affects pain sensation during and after an elective procedure of hip or knee replacement. The study's population will be divided to four groups: Group A- chronic use of Beta adrenergic receptor blockers undergoing total hip replacement, Group B- no use of Beta adrenergic receptor blockers undergoing total hip replacement, Group C- chronic use of Beta adrenergic receptor blockers undergoing total knee replacement and Group D- no use of Beta adrenergic receptor blockers undergoing total knee replacement. Each patient will be anesthetized using the same anesthesia protocol with pain assessment done by the ANI device intra operatively and by NRS score postoperatively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Nociceptive Pain

Currently open trials in the same condition.

NCT07321080 — Central Sensitisation in Nociceptive and Neuropathic Pain · active not recruiting
NCT07084935 — Comparison of the Surgical Pleth Index and the Nociception Level Index in the Pediatric Population · recruiting
NCT06443281 — Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury · recruiting
NCT06291363 — Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception. · Phase 4 · recruiting
NCT06044584 — Unveiling Physiological and Psychosocial Pain Components with an Artificial Intelligence Based Telemonitoring Tool · recruiting

Other Tel-Aviv Sourasky Medical Center trials

Trials by the same sponsor.

NCT07380737 — Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot · NA · recruiting
NCT07104136 — Improving Adherence to COPD Treatments in Primary Care · NA · enrolling by invitation
NCT07327021 — MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC · Phase 2 · recruiting
NCT07191249 — A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previousl · Phase 2 · not yet recruiting
NCT07235332 — Assessing Toxic Metal Exposure From Vegetarian/Vegan, Omnivorous, and Low-carb Diets in Israel. · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03498898 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tel-Aviv Sourasky Medical Center
Last refreshed: 16 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03498898.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing